Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

Press releases published on May 26, 2026

STRiV Forward Providing Transitional Living for Emerging Adults in Utah
Labopat diagnostics® goes live with Techcyte Fusion®, expanding access to digital pathology across Mexico
What is the Best Drug Rehab in Utah - Drug Rehabs Ranking & Comparison
Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference
MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2026 Financial Results
Canadian Pilot Joins Global Emergency Response as DRC Ebola Outbreak Surpasses 1,000 Cases
NANOBIOTIX Announces Closing of Global Offering
Dentsply Sirona Continues to Expand U.S. Distribution Network to Strengthen Access to its Digital Dentistry Solutions Across Key Regional Markets
Spyre Therapeutics to Participate in Upcoming June Investor Conferences
Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026
Jade Biosciences Announces First Participant Dosed in First-in-Human Phase 1 Clinical Trial of JADE201, a Novel Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody
Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)
Structure Therapeutics Announces Participation in Upcoming Investor Conferences
OrthoPediatrics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates
Lakefront ontvangt transparantieverklaring van Bank of America
Lakefront Receives Transparency Notification from Bank of America
Apogee Therapeutics to Host Conference Call to Report Part B 16-Week Data from the Phase 2 APEX Trial of Zumilokibart in Patients with Moderate-to-Severe Atopic Dermatitis on May 27, 2026

Share this page:

Sign up for:

Healthcare Times Utah

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.